Protalix BioTherapeutics
PLX
#8576
Rank
NZ$0.20 B
Marketcap
$2.83
Share price
-1.78%
Change (1 day)
22.94%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -NZ$21.45 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are NZ$38.05 Million. In 2023 the company made an earning of NZ$20.03 Million, an increase over its 2022 earnings that were of -NZ$20.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$21.45 Million-207.04%
2023 NZ$20.03 M-199.05%
2022 -NZ$20.23 Million-40.38%
2021 -NZ$33.93 Million-732.31%
2020 NZ$5.36 M-130.53%
2019 -NZ$17.58 Million189.85%
2018 -NZ$6.07 Million-95.29%
2017 -NZ$0.13 Billion308.12%
2016 -NZ$31.56 Million-32.37%
2015 -NZ$46.66 Million10.11%
2014 -NZ$42.37 Million-7.59%
2013 -NZ$45.85 Million
2011 -NZ$53.1 Million-19.39%
2010 -NZ$65.87 Million20.87%
2009 -NZ$54.49 Million32.26%
2008 -NZ$41.2 Million-5.46%
2007 -NZ$43.58 Million
2004 -NZ$0.29 Million12.35%
2003 -NZ$0.26 Million-11.1%
2002 -NZ$0.29 Million-57.03%
2001 -NZ$0.66 Million1.03%
2000 -NZ$0.66 Million-53.22%
1999 -NZ$1.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.18 Billion 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.11 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$2.07 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.40 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel